CoviDetect™ FAST – A multiplex assay for detection of COVID-19 on Real-Time PCR in 51 minutes
PentaBase’s CoviDetect™ FAST diagnostic assay is a real-time RT (Reverse transcriptase) PCR assay, which is based on highly sensitive technology that is used to detect SARS-CoV-2 virus in patients, without eliminating the possibilities of co-infections with other viruses or bacteria.
The assay can be applied to standard real-time PCR equipment and Nucleic Acid Extraction Instruments using standard procedures. With the use of CoviDetect™ FAST assay, detection of the RNA presence of the virus will provide a quick, sensitive, and selective nucleic Acid extraction, and real-time RT-PCR analysis in only 51 minutes.
SARS-CoV-2 MUTATIONS ASSAYS
PentaBase Develops Assays for COVID-19 Mutations
PentaBase is proud to be one of the only European companies that offer SARS-CoV-2 mutation assays, which can detect the more infectious variants, cluster B.1.1.7, cluster B.1.351/501YV2, cluster P.1, and mutation N439K.
With our CoviDetect™ COVID-19 Mutation RT-PCR Assays, genetic variations from positive SARS-CoV-2 samples can be detected quickly, sensitively, and selectively by real-time RT-PCR followed by a DNA melt analysis.
Results are for the detection of genetic variations N501Y, P681H, Del69-70, E484K, N439K, and A701V and we will always have an analysis in case of a new variant.
PentaBase is an innovative biotech company located in the heart of Denmark. We specialise in custom oligonucleotide production and development of in vitro diagnostic assays for real-time PCR with special focus on the detection of SARS-CoV-2 and somatic mutations in cancer.
For more than 10 years, PentaBase has created real-time PCR-based products for researchers and medical professionals exploring new treatments and helping patients worldwide. Our products are based on our proprietary technology, Intercalating Nucleic Acids (INAs®), providing unique abilities in analysis and manipulation of genetic material.
We believe in open-platform designs and are making all of our products compatible with standard equipment used in molecular biology facilities around the world.
Under 1% positive – 2 af 32 positive COVID-19 prøver testet positiv for ”den engelske variant”, 25% havde mutationer
FAQ RELATED TO COVID-19
Most frequent questions and answers
COVID-19/SARS CoV-2 is the definition of Severe Acute Respiratory Syndrom – Coronavirus 2, which is the strain of Coronavirus that causes the COVID-19, and is the virus responsible for the current pandemic.
Yes, PentaBase will test all samples for cluster B.1.1.7, cluster B.1.351/501YV2, cluster P.1 and Mutation N439K without further cost, to offer an even better service for all our customers.
PentaBase has become an active part in the fight against COVID-19. Through a rapid effort of our researchers, we developed a sensitive and specific multiplex RT qPCR version of the COVID-19 test, CoviDetect™. The test is unique as it allows testing of three times as many samples with the use of standard laboratory equipment.
With the use of our technology, we are able to detect SARS-CoV-2 and any of its mutations.
Yes, we are testing for COVID-19 and antibodies for COVID-19.
We are testing for COVID-19 through a sample from the throat with a special swab, and is collected by a medical professional.
Our COVID-19 test is a RT-PCR test and the sample will be analysed in our laboratory to detect any cases of COVID-19.
Our antibody test is conducted on serum prepared from venous blood collected from qualified personnel. For children between the ages 3-15, the sample is collected through the finger.
Our testing/detection service is offered to both private persons and companies in the need of a quick test service.
We do not provide COVID-19 tests for children under the age of 3.
For more information on our service for companies, click here.
PentaBase offers a travel certificate provided with results of the COVID-19 RT-PCR test and Antibody (IgM) test.
When your COVID-19 RT-PCR and antibody test result is ready, you will recieve a text message and an e-mail with a link to your COVID-19 travel certificate.
Read more about how PentaBase can help you in relation to travel here.
We offer COVID-19 test services for private people at our location in Odense, Esbjerg, Aarhus, Aalborg and Herlev.
Click here to book an appointment.
We offer COVID-19 test services for companies through a medical professional out to their desired location, or companies can come to our location in Odense, Esbjerg, Aarhus or Herlev.
We offer 4 services: Super Express, Express, Same Day and Next Day.
Super Express = You receive your test result after 2 hours.
Express = You receive your test result after 4 hours.
Same Day = You receive your test result during the same day you have got tested, no later than 20pm.
Next Day = You receive your test result during the next day, and no later than 20pm
Book your test here.
PentaBase provides a antibody Test (IgM/IgG), which can be booked through our website: https://www.pentabase.com/covid-19-detection-service/
PentaBase is testing for COVID-19 antibodies with the use of an enzyme-linked immunosorbent assay (ELISA) and a blood sample from a person, which makes it possible to detect for the presence of antibodies against SARS-CoV-2, the virus behind COVID-19.
Our COVID-19 test is based on our proprietary, patented technology and validated in close collaboration with Rigshospitalet, Copenhagen and Novo Nordisk.
Our COVID-19 test has a market-leading sensitivity and is therefore able to detect even small amounts of virus. With this sensitivity, it is possible to detect virus 2-4 days before it can be passed on to others.
If you, or someone you know, have been tested positive for COVID-19, you can read more about how to behave here.
The samples are handled anonymously, and the testing is done according to the GDPR-requirements.
We are always ready to answer any question you may have. Don’t hesitate to contact us!
Call +45 36 96 94 96 or send an email to moc.esabatnep@ofni